Stay updated on TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.” The clinical trial record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-21T14:33:56.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 while the page remained a 403 error.
    Difference
    0.2%
    Check dated 2026-10-14T16:05:45.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 error, with the footer revision updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T15:46:40.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The study page currently shows a 403 Forbidden error, indicating access is blocked for this URL rather than an update to the study's details. The site chrome remains, but the content is not retrievable.
    Difference
    0.5%
    Check dated 2026-09-30T16:23:27.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The study page now renders as a 403 Forbidden error page, showing the site header and footer but no study content, replacing the usual study details and related information.
    Difference
    18%
    Check dated 2026-09-23T19:38:29.000Z thumbnail image
  8. Check
    53 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.6 to v3.7.0, signaling a recent UI release while the underlying study information remains unchanged.
    Difference
    0.0%
    Check dated 2026-09-16T22:22:44.000Z thumbnail image

Stay in the know with updates to TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page.